Anti-atherosclerotic therapies: milestones, challenges, and emerging innovations
I Hetherington, H Totary-Jain - Molecular Therapy, 2022 - cell.com
Atherosclerosis is the main underlying pathology for many cardiovascular diseases (CVDs),
which are the leading cause of death globally and represent a serious health crisis …
which are the leading cause of death globally and represent a serious health crisis …
Deranged myocardial fatty acid metabolism in heart failure
T Yamamoto, M Sano - International journal of molecular sciences, 2022 - mdpi.com
The heart requires fatty acids to maintain its activity. Various mechanisms regulate
myocardial fatty acid metabolism, such as energy production using fatty acids as fuel, for …
myocardial fatty acid metabolism, such as energy production using fatty acids as fuel, for …
Statins and inflammation: new therapeutic opportunities in psychiatry
SW Kim, HJ Kang, M Jhon, JW Kim, JY Lee… - Frontiers in …, 2019 - frontiersin.org
Statins, which are widely used to treat hypercholesterolemia, have anti-inflammatory and
anti-oxidant effects. These are thought to be responsible for the potential effects of statins on …
anti-oxidant effects. These are thought to be responsible for the potential effects of statins on …
Effect of hypercholesterolaemia on myocardial function, ischaemia–reperfusion injury and cardioprotection by preconditioning, postconditioning and remote …
Hypercholesterolaemia is considered to be a principle risk factor for cardiovascular disease,
having direct negative effects on the myocardium itself, in addition to the development of …
having direct negative effects on the myocardium itself, in addition to the development of …
Statins: from cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases
C Ulivieri, CT Baldari - Pharmacological Research, 2014 - Elsevier
Statins, a class of drugs that act as inhibitors of cholesterol biosynthesis and protein
isoprenylation, have been proposed as immunomodulatory agents due to their potent effects …
isoprenylation, have been proposed as immunomodulatory agents due to their potent effects …
Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?
P Balakumar, S Kathuria, G Taneja, S Kalra… - Journal of molecular and …, 2012 - Elsevier
Statins are widely used in the treatment of dyslipidemia and associated cardiovascular
abnormalities including atherosclerosis, hypertension and coronary heart disease. Needless …
abnormalities including atherosclerosis, hypertension and coronary heart disease. Needless …
[HTML][HTML] Protective effects of atorvastatin and quercetin on isoprenaline-induced myocardial infarction in rats
Myocardial infarction (MI) continues to be a major public health problem in the world. Statins
exhibit cardio-protective effects by several mechanisms beyond their lipid lowering activity …
exhibit cardio-protective effects by several mechanisms beyond their lipid lowering activity …
Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway
NM Al-Rasheed, MM Al-Oteibi… - Drug Design …, 2015 - Taylor & Francis
Simvastatin (SIM) is a lipid-soluble inhibitor of hydroxy-3-methylglutaryl coenzyme A
reductase with multiple reported therapeutic benefits. The present study was designed to …
reductase with multiple reported therapeutic benefits. The present study was designed to …
A step ahead of PPARγ full agonists to PPARγ partial agonists: therapeutic perspectives in the management of diabetic insulin resistance
S Chigurupati, SA Dhanaraj, P Balakumar - European journal of …, 2015 - Elsevier
Described since long as a member of the nuclear receptor superfamily, peroxisome
proliferator-activated receptors (PPARs) regulate the gene expression of proteins involved in …
proliferator-activated receptors (PPARs) regulate the gene expression of proteins involved in …
[HTML][HTML] Atorvastatin protects myocardium against ischemia-reperfusion injury through inhibiting miR-199a-5p
YB Zuo, YZ Wang, HJ Hu, W Cui - Cellular Physiology and Biochemistry, 2016 - karger.com
Objective: This study aimed to evaluate the protective effects of atorvastatin against
myocardial ischemia/reperfusion (I/R) injury in cardiomyocytes and its possible underlying …
myocardial ischemia/reperfusion (I/R) injury in cardiomyocytes and its possible underlying …